Clinical Trial Update: Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD [Phase 2]

View source ↗

Summary

A Phase 2 multi-center trial evaluating Panosyl-Isomaltooligosaccharides as an adjunct to PPI therapy for gastroesophageal reflux disease, currently not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Panosyl-Isomaltooligosaccharides (panosyl-isomaltooligosaccharides)

Snippet

Sponsor: Microbiome Health Sciences | Conditions: Gastroesophageal Reflux | Phase 2 | Status: ACTIVE_NOT_RECRUITING